Atherectomy Devices Market

Global Market Study on Atherectomy Devices: Advancements in Rotational Technology and Growing Acceptance of Peripheral Intervention Devices to Aid Steady Revenue Generation

Atherectomy Devises Market Segmented By Rotational Atherectomy Devices, Directional / excisional Atherectomy Devices, Orbital Atherectomy Devices, Laser Ablation Atherectomy Devices Device Type with Coronary Artery Diseases, Peripheral Artery Diseases Indication

Industry: Healthcare

Published Date: May-2022

Format: PPT*, PDF, EXCEL

Delivery Timelines: Contact Sales

Number of Pages: 219

Report ID: PMRREP3516

Report Price

$ 4900*

Buy Now

Atherectomy Devices Market Outlook (2022 - 2026)

The Atherectomy Devices Market witnessed a CAGR of 10% between 2014 and 2021. The global Atherectomy Devices Market is expected to have 11.8% CAGR between 2022 and 2026. In 2022, the global Atherectomy Devices Market size is US$ 991.1 million, which is projected to reach US$ 1,546.1 million by the year 2026.

Attribute Key Insights

Atherectomy Devices Market Size (2022)

US$ 991.1 Mn

Projected Market Value (2026)

US$ 1,546.1 Mn

Global Market Growth Rate (2022-2026)

11.8% CAGR

Share in parent market

56.7%

Atherectomy Devices Market Demand Analysis (2013-2021) v/s Market Outlook (2022-2026)

The Atherectomy Devices Market is expected to grow at a CAGR of 11.8% during the forecast period between 2022 and 2026. The increased demand for minimally invasive treatments as well as the growing pool of patients is expected to drive the growth of the worldwide atherectomy devices market. The increased emphasis on technical improvements and the launch of new products is also expected to fuel market growth in the near future.

What is expected to keep the Hopes High for Atherectomy Devices Market?

  • An increase in the patient pool suffering from Atherosclerosis, Diabetes, and Obesity

The rising prevalence of orthopedic disorders such as bone tumors and osteomyelitis is boosting the market growth. Atherectomy Devices are most commonly used to treat chronic osteomyelitis. Going forward, the increase in sports injuries and the other forms of trauma, bone lesions, and bone fractures are expected to fuel the market growth.

  • Growing Incidences Of Peripheral Arterial Diseases and Coronary Artery Diseases

Growing incidences of peripheral artery diseases (PAD) and Coronary Artery Diseases (CAD) are expected to accelerate the Atherectomy Devices market. Research states that CADs and PADs affect 2 million Americans every year. Smoking, diabetes, and hypertension are the other factors leading to the rising occurrences of PADs and CADs. Atherectomy Devices are important in the treatment and management of peripheral artery disease (PAD). The devices provide several advantages, including a reduced possibility of complications and a better level of comfort throughout surgeries as compared to conventional treatments.

atherectomy-devices-market

  • An Increase In Adoption Of Laser Atherectomy Devices

The rapidly expanding adoption of Laser Atherectomy Devices is likely to drive market expansion. As compared to mechanical systems, these devices provide several benefits like adaptability, enhanced efficiency, and the elimination of the need for embolic protection devices. Furthermore, laser-embedded atherectomy devices are capable of removing thrombi, dissolving procoagulant reactants, and debulking the underlying plaque without damaging the surrounding tissue. The modern laser atherectomy devices also provide exceptional precision along with a shorter recovery period and hospital stay. Hence, the increase in the adoption of laser atherectomy devices is expected to boost the market in the near future.

  • Technological Advancements

The increasing focus on technological advancements is estimated to bolster the market in the years to come. Furthermore, extensive research backing rapid expansion of medical infrastructure is expected to drive market growth during the forecast period.

What restraints is the Atherectomy Devices Market subject to?

  • “Lack of awareness among people”

People in developing countries have a limited understanding of the easy availability of disease diagnostics and therapies, which is expected to impede market expansion in the approaching years. Furthermore, scarcity of skilled surgeons is expected to limit market growth in the near future. However, relentless efforts made by the governments coupled investments are expected to promote the growth of the market in the upcoming period. Furthermore, the leading companies are focusing on emerging economies, which have the potential to evolve as mentioned above.

How has Covid-19 affected the Atherectomy Devices Market?

“Significant Decrease in Demand”

The COVID-19 pandemic wreaked havoc on the global economy, and it had a negative impact on the Atherectomy Devices Market between March 2020 and September 2021. The advent of COVID-19 led to a decrease in demand for Atherectomy Devices because the hospitals were flooded with Covid-19 patients. The unexpected outbreak of SARS-CoV-2 resulted in lockdown around the world, which caused a shutdown in significant areas of the global economy and caused supply chain disruptions, limiting commerce and transit of commodities and affecting industrial growth. The COVID-19 pandemic harmed the market by causing financial difficulties for enterprises as well as affecting output and demand, but the market has bounced back after September 2021

Competitive Landscape

The Atherectomy Devices industry is moderately competitive and highly consolidated due to the presence of several large players. Key players in the market are focusing on mergers and acquisitions as the industry is in the growth phase. Companies are making strategic decisions regarding organic as well as inorganic expansion in order to expand their product portfolios and grow their market share.

  • Royal Philips launched peripheral and coronary artery applications, including the Nexcimer laser system, in North America in November 2021. The Nexcimer laser system can be used for peripheral and coronary atherectomy as well as lead extraction procedures.
  • Cardiovascular Systems, Inc. received CE Mark in January 2021 for its Diamondback 360 Coronary Orbital Atherectomy System (OAS), which combines differential sanding and pulsatile forces to treat all calcium modalities, including nodular, eccentric (irregular), and concentric calcium modalities (ring-shaped).

Atherectomy Devices Market Industry Report Scope

Attribute Details

Forecast Period

2022-2026

Historical Data Available for

2013-2021

Market Analysis

US$ Mn/Bn for Value

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Key Countries Covered

  • U.S.
  • Canada
  • Germany
  • Italy
  • France
  • U.K.
  • Spain
  • Russia
  • India
  • China
  • Japan
  • UAE
  • Australia

Key Market Segments Covered

By Indication

Key Companies Profiled

  • Medtronic Plc.
  • Boston Scientific Corporation
  • Cardiovascular Systems, Inc.
  • Avinger, Inc.
  • Koninklijke Philips N.V. (Spectranetics + Volcano)
  • Others.

Customization & Pricing

Available upon Request

Atherectomy Devices Market Categorization

Atherectomy Devices Market by Indication

  • Coronary Artery Diseases
  • Peripheral Artery Diseases

Atherectomy DevicesMarket by Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)

To know more about delivery timeline for this report Contact Sales

Companies Covered in This Report

  • Medtronic Plc.
  • Boston Scientific Corporation
  • Cardiovascular Systems, Inc.
  • Avinger, Inc.
  • Koninklijke Philips N.V. (Spectranetics + Volcano)

Frequently Asked Questions

In 2022, the Atherectomy Devices Marketstands at USD 919.1 million, and it is expected to reach USD 1,546.1 million by 2026 at a CAGR of 11.8%.

Atherectomy Devices Market exhibited a 10% CAGR between 2013 and 2021.

Lack of awareness among people in the developing countries is the key restraint in the Atherectomy Devices Market.

The increasing Prevalence of Peripheral Arterial Diseases and Coronary Artery Diseases along with the Increase in the Adoption of Laser Atherectomy Devices are the key factors driving the growth of the market.

Medtronic Plc., Boston Scientific Corporation, Cardiovascular Systems, Inc., Avinger, Inc., and Koninklijke Philips N.V. (Spectranetics + Volcano) are among the top players in the market.

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate